May 29, 2024:

A Big Ten Cancer Research Consortium (Big Ten CRC) study was published in Nature Communications on February 1, 2024. The article is titled, “Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.”

Read More

May 28, 2024:

Monika Joshi, MD, MRCP, has been re-appointed as the chief scientific officer of the Big Ten Cancer Research Consortium.

Read More

May 15, 2024:

The Big Ten Cancer Research Consortium (Big Ten CRC) is set to participate in the American Society of Clinical Oncology® (ASCO) 2024 Annual Meeting in Chicago from May 31 to June 4. During the event, three Big Ten CRC studies will be presented, working group meetings will take place, and the Big Ten CRC will host a joint reception with Hoosier Cancer Research Network (HCRN). The Big Ten CRC will also be represented in the exhibit hall at HCRN’s booth, #37113.

Read More

May 9, 2024:

Raymond J. Hohl, MD, PhD, was recently named chair of the Cancer Center Directors Committee for the Big Ten Cancer Research Consortium (Big Ten CRC). In this role, Dr. Hohl will help guide strategic priorities for the Big Ten CRC as the consortium enters its second decade. Dr. Hohl has been a member of the leadership committee since the consortium’s founding in 2013 and succeeds Howard Bailey, MD, director of the University of Wisconsin Carbone Cancer Center, as the committee chair. Read More

May 7, 2024:

The Big Ten Cancer Research Consortium (Big Ten CRC) recently appointed Oana Danciu, MD, as chair of the consortium’s steering committee. Dr. Danciu is associate director of clinical research at the University of Illinois Cancer Center, a breast oncologist at UI Health, and associate professor in the Division of Hematology and Oncology at the University of Illinois College of Medicine Chicago. She succeeds Vijaya Raj Bhatt, MBBS, MS, of the University of Nebraska Medical Center, as chair of the committee. Read More

May 3, 2024:

The Big Ten Cancer Research Consortium (Big Ten CRC) is excited to announce the release of a new public service announcement (PSA), showcasing the importance of scientific research collaboration among the Big Ten Cancer Centers. This PSA appears on the Big Ten Network.

Read More

April 12, 2024:

The Big Ten Cancer Research Consortium (Big Ten CRC) is excited to announce the release of our new podcast, “Adolescent and Young Adult Cancer in Focus.”

In this podcast, members of the Big Ten CRC and their colleagues discuss current issues and topics in adolescent and young adult (AYA) cancer research and survivorship. Its purpose is to inform, increase awareness, and educate Big Ten CRC members, families, and patients about AYA oncology.

Read More

December 3, 2023: 

Bringing the best ideas forward, pulling expertise across cancer centers, connecting through mentorships, and ensuring racial, ethnic and gender diversity in clinical trial participation are critical components of the Big Ten Cancer Research Consortium (Big Ten CRC), according to Chief Scientific Officer Monika Joshi, MD, MRCP, from the Penn State Cancer Institute, who spoke at the Big Ten CRC Summit 2023, which brought together more than 110 researchers, investigators, cancer centers, and industry participants. Read More

September 1, 2023: 

The Big Ten Cancer Research Consortium Diversity Committee talks with investigators, industry sponsors and patient advocates on how to work together to develop policies and strategic priorities for the Big Ten CRC that will foster growth, learning, and change that will create a more equitable environment for patients enrolled in clinical trials. Episode one: “Conversation with the Co-Chairs” is now available on Spotify and Amazon Music! Read More

September 6, 2023:

The Big Ten Cancer Research Consortium’s annual summit is being held at Big Ten Conference Headquarters in Chicago. The summit will take place on Saturday, September 30, 2023, and is hosted by the University of Wisconsin Carbone Cancer Center. Read More